Skip to main content

Month: December 2020

IDEX Biometrics to Present at the LD Micro Main Event Virtual Conference, 15 Dec 2020

Oslo, Norway, 7 December 2020: IDEX Biometrics ASA (OSE: IDEX and OTCQB: IDXAF) is a leading provider of advanced fingerprint identification and authentication solutions. CEO Vince Graziani will present live to a virtual audience at the LD Micro Main Event Conference on Tuesday 15 December 2020.Following the conference a webcast replay of the presentation will be available at the Investor section of the company’s website www.idexbiometrics.com.For further information contact:Marianne Bøe, Investor RelationsE-mail: marianne.boe@idexbiometrics.comTel: + 47 918 00186Derek P. D’Antilio, Chief Financial OfficerE-mail: derek.dantilio@idexbiometrics.comTel: +1 978 273 1344About IDEX BiometricsIDEX Biometrics ASA (OSE: IDEX and OTCQB: IDXAF) is a leading provider of fingerprint identification technologies offering simple, secure and personal...

Continue reading

Cardinal Energy Ltd. Announces Private Placement

CALGARY, Alberta, Dec. 07, 2020 (GLOBE NEWSWIRE) — Cardinal Energy Ltd. (“Cardinal” or the “Company“) (TSX: CJ) announces that it has entered into subscription agreements for a non-brokered private placement of approximately $16,920,833 principal amount of 2nd lien secured notes (the “Notes“) issued at a 4% discount for gross proceeds of $16,244,000. As part of the Note offering, each subscriber is also required to subscribe for a pro rata number of units (the “Units“) totaling 8,122,000 Units, at a subscription price of $0.50 per Unit for gross proceeds of $4,061,000.The Notes will bear interest at 12% per annum (all interest will accrue semi-annually and be added to the principal amount outstanding and will be payable on maturity) and will be due on June 30, 2022, subject to extension...

Continue reading

Nokia to lead the EU’s 6G project Hexa-X

Press ReleaseNokia to lead the EU’s 6G project Hexa-XNokia is the project leader for Hexa-X, the European Commission’s 6G flagship initiative for research into the next generation of wireless networksThe Hexa-X vision is to connect human, physical and digital worlds with a fabric of 6G technology enablersHexa-X is the first official research initiative across the industry ecosystem to accelerate and foster 6G research and drive European leadership in the 6G era07 December 2020Espoo, Finland – Nokia leads the way in the next generation of wireless networks as the overall project leader for Hexa-X, the European Commission’s 6G flagship initiative for research that will drive the overall 6G vision. The project goals include creating unique 6G use cases and scenarios, developing fundamental 6G technologies and defining a new architecture...

Continue reading

NXP Announces a Complete Suite of Radar Sensor Solutions that Can Surround Vehicles in a 360-degree Safety Cocoon

New sensing solutions cover all radar segments from NCAP corner to 4D imaging radarScalable portfolio approach for optimum design and software re-use, reduced R&D effort aims to deliver faster time to marketMarket leading radar IP based on volume-proven advanced process technologiesEINDHOVEN, The Netherlands, Dec. 07, 2020 (GLOBE NEWSWIRE) — NXP Semiconductors, the leader in automotive radar, has announced a complete suite of new radar sensor chipset solutions that can surround vehicles in a 360-degree safety cocoon and enable the identification and classification capabilities of imaging radar. The solutions, comprised of new NXP radar processors and 77GHz transceivers, offer carmakers flexible and scalable configurations that address NCAP requirements for corner and front radar applications while offering 4D imaging radar’s...

Continue reading

ERYTECH annonce les résultats positifs de l’étude de phase 2 dans la leucémie aiguë lymphoblastique avec eryaspase lors du congrès annuel de l’ASH 2020

Webcast aujourd’hui, lundi 7 décembre à 16h00 (heure de Paris)L’étude confirme le potentiel d’eryaspase comme option de traitement intéressante pour les patients atteints de leucémie aiguë lymphoblastique (LAL) ayant développé une hypersensibilité à l’asparaginase pégyléeLYON, France, 07 déc. 2020 (GLOBE NEWSWIRE) — ERYTECH Pharma (Euronext Paris et Nasdaq : ERYP), société biopharmaceutique de stade clinique qui développe des thérapies innovantes en encapsulant des médicaments dans les globules rouges, annonce aujourd’hui les résultats de l’étude de phase 2 avec eryaspase chez les patients atteints de LAL, conduite par l’Organisation nordique d’hématologie et d’oncologie pédiatrique (NOPHO), qui ont été présentés hier par le Dr. Line Stensig Lynggaard lors du 62econgrès annuel de l’American Society...

Continue reading

TransGlobe Energy Corporation Announces an Investor Conference Call and Webcast

AIM & TSX: “TGL” & NASDAQ: “TGA”CALGARY, Alberta, Dec. 07, 2020 (GLOBE NEWSWIRE) — TransGlobe Energy Corporation (“TransGlobe” or the “Company”) is pleased to announce that the Company will hold a conference call for investors followed by a Q&A session with senior management.INVESTOR CONFERENCE CALL AND WEBCASTThe call will be held at 5:00pm GMT / 10:00am MST on Tuesday, December 8, 2020Details for the conference call are as follows:Conference ID: 1499429Conference Call Title: TransGlobe Conference Call and WebcastCORPORATE PRESENTATIONFurther to the Company’s news release dated December 1, 2020 announcing the agreement with the Egyptian General Petroleum Corporation to merge its three existing Eastern Desert concessions (the West Gharib, West Bakr and North West Gharib concessions) into a...

Continue reading

VAALCO Announces Completion of 3-D Seismic Survey Data Acquisition Over Entire Etame Marin Block

HOUSTON, Dec. 07, 2020 (GLOBE NEWSWIRE) — VAALCO Energy, Inc. (NYSE: EGY; LSE: EGY) (“VAALCO” or the “Company”) today announced that the acquisition of three dimensional (“3-D”) seismic data at the Etame Marin block offshore Gabon has been completed.HighlightsCompleted the acquisition of nearly 1,000 square kilometers of new dual-azimuth proprietary 3-D seismic data over the entire Etame Marin block which will be used to optimize and de-risk future drilling locations and potentially identify new drilling locations;Enhances sub-surface imaging by merging legacy data with newly acquired seismic allowing for the first continuous 3-D seismic over the entire block;Estimates the total costs of both the acquisition and processing of seismic data to be approximately $14 to $16 million gross over the period from Q4 2020 through Q4 2021 and...

Continue reading

“Grindeks” unveils new look

“Grindeks” unveils new lookJSC “Grindeks” announces an update to its corporate brand, including refreshed logo, custom typeface and style. To assure the visual sustainability, “Grindeks” proudly presents the novelty – Grindelia flower symbol, as one of the companies’ recognition signs, honouring the first Latvian origin pharmacist, doctor and chemist David Hireonymus Grindel.For more than 20 years company is known and trusted under the brand name “Grindeks”. Company’s name holds the history, traditions and evolution of all Latvian pharmaceutical industry. “Grindeks” launched novel brand vision to provide the best health support for every person worldwide and become a world-class pharmaceutical company.Growth, simplicity and humanity are the new “Grindeks” brand values, that will deliver experience and knowledge collected over the years...

Continue reading

“Grindeks” paziņo par zīmola jauninājumiem

“Grindeks” paziņo par zīmola jauninājumiemAkciju sabiedrība “Grindeks” paziņo par zīmola jauninājumiem, tostarp atsvaidzinātu logotipu, pielāgotu burtveidolu un stilu. Lai nodrošinātu vizuālu ilgtspēju, “Grindeks” ar lepnumu iepazīstina ar inovāciju – grindēlijas zieda simbolu kā vienu no uzņēmuma atpazīšanas zīmēm, lai godinātu pirmo latviešu izcelsmes farmaceitu, ārstu un ķīmiķi Dāvidu Hieronīmu Grindeli.Jau vairāk nekā 20 gadus uzņēmuma atpazīstamību, uzticamību un reputāciju vairo “Grindeks” zīmols. Uzņēmuma nosaukums ir visas Latvijas farmācijas tradīciju, attīstības un vēstures kopums. Šodien “Grindeks” ir nācis klajā ar jaunu zīmola vīziju – sniegt vislabāko veselības atbalstu ikvienam cilvēkam visā pasaulē un kļūt par pasaules nozīmes farmācijas uzņēmumu.Cilvēcīgums, vienkāršība un izaugsme ir “Grindeks” jaunās vērtības, kas saprotamā...

Continue reading

GENFIT announces the successful completion of a key milestone in the partial buyback and amendment of its OCEANEs

Partial buyback of 47.6% of the OCEANEs for a total amount of 47.48 million euros85.70 million euros convertible debt potentially cancelled, leading to a residual debt of 94.30 million euros (versus 180 million euros previously)Buyback subject to October 2025 maturity extension and conversion ratio increase from 1:1 to 1:5.5Final approval of terms of OCEANEs subject to the January 2021 shareholders’ and bondholders’ general meetingsLille (France), Cambridge (Massachusetts, United States), December 7, 2020 – GENFIT (Nasdaq and Euronext: GNFT), a late-stage biopharmaceutical company dedicated to improving the lives of patients with metabolic and chronic liver diseases, today announces that it has signed bond repurchase agreements with holders of its convertible bonds maturing in October 2022 (the “OCEANEs”).Pascal Prigent, CEO of GENFIT,...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.